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A total of 26% of the pneumococci isolated from an outpatient clinic in Nairobi, Kenya, during 1991 to 1992
had intermediate levels of penicillin resistance. Gene fingerprinting and DNA sequencing were used to
distinguish the penicillin-binding protein (PBP) LA, 2B, and 2X genes in 23 resistant isolates. Isolates were
grouped into those that had identical forms of each of the three PBP genes (fingerprint groups) and those that
had identical rRNA gene restriction patterns (ribotypes). Both methods divided the isolates into 11 groups. In
a few cases, horizontal gene transfer appeared to have distributed an identical altered PBP gene into different
pneumococcal lineages. Eight isolates were indistinguishable by ribotyping or multilocus enzyme electrophore-
sis and contained identical PBP LA genes. Although these isolates were therefore members of the same clone,
they were divided into two fingerprint groups which contained different PBP 2X and 2B genes. Presumably,
members of this clone have acquired different altered PBP 2X and 2B genes on two separate occasions. One of
these fingerprint groups contained isolates of serotype 14, whereas the other contained isolates of both serotypes
14 and 7. The identification of isolates in the latter group that are identical by all criteria, except serotype,
implies the occurrence of a change in serotype. The predominant serotypes of the penicillin-resistant
pneumococci from Nairobi were serotypes 14 and 19. In both cases, isolates of the same serotype which
required the same MIC of penicillin were not members of a single clone, indicating that identity of serotype and
MIC are not sufficient criteria for defining clones of resistant pneumococci even when the bacteria are isolated
from a single clinic.
Penicillin resistance in Streptococcus pneumoniae (the
pneumococcus) is entirely due to the development of altered
forms of penicillin-binding proteins (PBPs) that have de-
creased affinity for P-lactam antibiotics (9, 30). In high-level
penicillin-resistant pneumococci (requiring MICs of >1 pg
of benzylpenicillin per ml), there are reductions in the
affinities of at least four of the five high-molecular-weight
PBPs (1A, 1B, 2A, 2X, and 2B). Low-affinity forms of PBPs
appear to have arisen by interspecies recombinational
events, presumably mediated by genetic transformation, that
have replaced parts of the pneumococcal PBP genes with the
corresponding regions from the homologous PBP genes of
closely related species (6). Consequently, the PBP genes of
penicillin-resistant pneumococci have a mosaic structure,
consisting of regions that are very similar to the correspond-
ing regions in the genes from penicillin-susceptible pneumo-
cocci and regions that differ by as much as 20% in nucleotide
sequence (6, 7, 14, 18).
Although penicillin-resistant or multiply antibiotic-resis-
tant pneumococci have been reported from many countries
(1, 13, 16, 19), there is little information on the relationships
among resistant isolates recovered within countries or in
different countries or continents. In most countries, resis-
tance to penicillin is found predominantly in a small number
of serotypes, e.g., serotypes 23F and 6B in Spain (16) and
serotypes 19A, 6B, and 14 in South Africa (13). Analysis of
resistant pneumococci by comparing the electrophoretic
mobilities of their PBPs on sodium dodecyl sulfate-polyac-
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rylamide gels suggested that they could be grouped into
families (12). More detailed analyses have confirmed the
existence of major clones of penicillin-resistant pneumo-
cocci that at present appear to be largely restricted geo-
graphically (4, 20, 21, 23, 29). An exception is the serotype
23F clone of multiply antibiotic-resistant pneumococci,
which is very common in Spain, predominates in the United
Kingdom, and has been identified recently in the United
States (20, 21), South Africa (3, 29), and Mexico (3).
Pneumococci are naturally transformable. At least in the
laboratory, transformation provides an efficient mechanism
for the exchange of chromosomal genes, and in nature it
might be expected to mediate the spread of altered PBP
genes from resistant pneumococci into susceptible strains, to
produce new resistant strains (4). Any attempt to understand
the epidemiology of penicillin-resistant pneumococci must
therefore be able to distinguish between the spread of
resistant isolates (clonal spread) and the spread of resistance
genes (horizontal spread). This can be achieved by using
methods that can index both the overall genetic relatedness
between isolates and the relatedness of their penicillin resis-
tance (PBP) genes (4, 21). Resistant pneumococci that are
not closely related overall but that contain identical altered
PBP genes can then be proposed to have arisen by horizontal
spread, whereas isolates that are indistinguishable in terms
of both their overall relatedness and the relatedness of their
altered PBP genes are the result of clonal spread.
DNA sequencing or, more conveniently, DNA fingerprint-
ing with restriction enzymes that cut frequently provides
suitable ways of distinguishing the PBP genes of penicillin-
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TABLE 1. Properties of penicillin-resistant pneumococci from Nairobia
Isolate Patient Specimen PBP 1A PBP 2X PBP 2B Serote MIC Fingerprint Ribotypeno. type allele allele allele otyp (lg/ml) group group
86014 1 SP 1* 1 1 14 0.5 I 1
100509 1 SP 1 1 1 14 0.5 I 1
100506 2 SP 1 1 1 14 0.25 I 1
132207 2 SP 1 1 1 14 0.5 I 1
132206 3 SP 1* 2* 2* 7 0.25 II 1
142145 4 SP 1* 2* 2 7 0.5 II 1
100511 5 BC 1* 2* 2* 14 0.5 II 1
100503 6 SP 1 2 2 14 0.5 II 1
85990 7 SP 2 3 3* 19 0.25 III 2
86022 8 TS 2 3 3 19 0.25 III 2
86012 9 TS 2 3 3 19 0.25 III 2
85997 10 SP 3 4 4 19 0.12 IV 3
132223 11 SP 3 4 4 19 0.12 IV 4
142162 12 BC 4 5 5 10 0.5 V 5
142163 12 BC 4 5 5* 10 0.5 V 5
100494 13 SP 5 6 6* 16 0.25 VI 6
100496 14 SP 5 6 6 16 0.25 VI 6
100512 15 SP 6 7 7 23 0.12 VII 7
100520 15 BC 6 7 7 23 0.25 VII 7
86016 16 SP 7* 8* 8 19 0.12 VIII 8
86007 17 SP 7* 8* 9 11 0.12 IX 9
85983 2 PNS 7* 8* 5* 9 0.25 X 10
86003 18 PNS 8 9 10* 15 0.25 XI 11
R6 Si Si Si NE 0.008
a Asterisks indicate cases in which DNA sequencing was used to further investigate the identity or nonidentity of PBP genes that gave the same fingerprints
(see text). SP, sputum; BC, blood culture; TS, throat swab; PNS, pernasal swab; NE, nonencapsulated. All isolates were from Kenya, with the exception of R6,
which was from the United States.
resistant pneumococci (4), whereas multilocus enzyme elec-
trophoresis (MLEE) or rRNA gene restriction pattern anal-
ysis (ribotyping) provides methods to assess the overall
relatedness of isolates (11, 28). By these approaches, the
identification of clones of penicillin-resistant pneumococci
and the significance of horizontal spread of resistance genes
and putative serotype changes in the spread of penicillin
resistance have been demonstrated (4, 21).
Very little information is available on the frequency of
penicillin-resistant pneumococci from African countries
(other than South Africa) or other developing countries in
which pneumococcal disease is common and in which anti-
biotics are often available without prescription. During a
study of a cohort of human immunodeficiency virus-positive
patients attending an outpatient clinic in Nairobi, Kenya, we
have encountered a very high incidence of invasive pneumo-
coccal disease (2). In the present paper, we report a 26%
incidence of penicillin resistance in pneumococci from this
group and demonstrate a considerable diversity in the peni-
cillin-resistant pneumococci obtained in this single clinic
over a short period of time that is not fully revealed by
serotyping. We also provide further examples of the signif-
icance of the horizontal transfer of PBP genes and putative
serotype changes in the spread of penicillin resistance in
pneumococci.
MATERIALS AND METHODS
Growth media and strains. Pneumococci were grown in
brain heart infusion broth plus 0.5% yeast extract or Todd-
Hewitt broth or on brain heart infusion agar containing 5%
defibrinated sheep's blood as described previously (22).
Serotyping was performed by the Central Public Health
Laboratories, Colindale, United Kingdom, and was kindly
rechecked by the Department of Bacteriology, Statens Se-
ruminstitut, Copenhagen, Denmark. The pneumococcal iso-
lates used in this work (Table 1) were clinically relevant
strains obtained from blood, lung aspirate, sputum, or per-
nasal swabs from bacteriological investigations of patients
studied at the Wellcome Trust-Kenya Medical Research
Institute HIV Project, Nairobi, Kenya, during 1991 to 1992.
Three pairs of strains (100506 and 132207, 142162 and
142163, and 100512 and 100520) were from samples taken
during the course of a single episode of pneumococcal
disease. The others were all from different patients or, in two
cases (86014 and 100509 and 100506 and 85983), from the
same patient but were obtained from different episodes of
disease separated by at least 4 months.
PBP gene fingerprinting. The PBP 1A, 2B, and 2X genes
were amplified from chromosomal DNA by the polymerase
chain reaction (PCR), and gene fingerprints were obtained as
described previously (4). Briefly, the amplified fragments
were gel purified with GeneClean (Bio 101, Inc., La Jolla,
Calif.) and were digested with restriction enzymes, end
labeled with [32P]deoxynucleoside triphosphate, fraction-
ated on a 6% nondenaturing polyacrylamide gel, and auto-
radiographed to produce gene fingerprints. The enzymes
Hinfl and DdeI plus MseI were used for fingerprinting the
PBP 1A and PBP 2X genes, and StyI and Hinfl were used for
the PBP 2B gene. pBR322 DNA digested with HpaII and end
labeled as described above was used as molecular size
markers. The fingerprint patterns on the X-ray films were
digitized and compared by using a Summasketch II Plus
digitizer tablet (Summagraphics, Inc., Seymour, Conn.) and
MolMatch software (Ultra-Violet Products Ltd., Cambridge,
United Kingdom).
Direct sequencing of PCR-amplified DNA fragments. The
PBP lA, 2B, and 2X genes were amplified by the PCR as
described above, except that biotin was incorporated at the
5' end of each of the upstream PCR primers, by using a
VOL. 61, 1993
4384 KELL ET AL.
biotinylated phosphoramidite for the final nucleotide addi-
tion step during synthesis. The amplified fragments were gel
purified with GeneClean, and the biotinylated and nonbio-
tinylated DNA strands were separated with avidin-coated
paramagnetic beads (Dynal UK, Ltd., Wirral, Merseyside,
United Kingdom) as described by Hultman et al. (10). DNA
sequencing was carried out on the single-stranded DNA by
using the Sequenase version 2 kit (U.S. Biochemicals Corp.,
Cleveland, Ohio). The regions of the PBP genes that were
sequenced were those that were the most variable in unre-
lated penicillin-resistant pneumococci (6, 14, 18). The se-
quences of the primers (using the numbering found in
references 8, 15, and 17) corresponded to nucleotides 2461 to
2477 and 3118 to 3097 for the PBP 1A gene; nucleotides 995
to 1015, 1270 to 1290, 1801 to 1781, and 2316 to 2292 for the
PBP 2B gene; and nucleotides 959 to 980 and 2285 to 2251 for
the PBP 2X gene.
MLEE. Pneumococci were grown at 37°C in 200 ml of
brain heart infusion broth plus 0.5% yeast extract and were
harvested in late exponential phase (about 8 x 108 CFU/ml),
and cell extracts were prepared as described by Coffey et al.
(4). Techniques for starch gel electrophoresis and enzyme
staining have been described elsewhere (27). The enzymes
analyzed were indophenol oxidase, alcohol dehydrogenase,
leucyl-alanine peptidase, leucyl-glycyl-glycine peptidase,
phenylalanyl-leucine peptidase, leucine aminopeptidase, nu-
cleoside phosphorylase, 6-phosphogluconate dehydroge-
nase, esterase, glyceraldehyde-3-phosphate dehydrogenase
(NADP dependent), carbamylate kinase, hexokinase, gluta-
mate dehydrogenase, adenylate kinase, phosphoglucose
isomerase, fructokinase, diaphorase, and lactate dehydroge-
nase. The differences between isolates were converted into a
distance matrix, and the relatedness of the isolates was
represented by a neighbor-joining tree (26).
Detection of restriction fragment length polymorphisms
around the rRNA genes (ribotyping). Chromosomal DNA
was prepared essentially as described by Pitcher et al. (25),
with the addition of mutanolysin (20 p,g/ml) to aid lysis.
Approximately 5 p,g of EcoRI-digested DNA was fraction-
ated on an 0.8% agarose gel and, after transfer to nylon
membranes (Hybond N) by vacuum blotting (Vacu-aid;
Hybaid, Ltd., Teddington, United Kingdom), was probed
with a digoxigenin-labeled cDNA made by reverse transcrip-
tion of 16S plus 23S rRNA from Eschenichia coli (Boehr-
inger-Mannheim, Lewes, United Kingdom) by using a mod-
ification of the method for making biotinylated probes
described by Pitcher et al. (24). Membranes were prehybrid-
ized, hybridized at 50°C, and washed at the same tempera-
ture, and hybridizing DNA fragments were detected under
the conditions recommended in the digoxigenin lumines-
cence detection kit (Boehringer-Mannheim).
Nucleotide sequence accession numbers. The sequences
have been submitted to the EMBL data library under the
accession numbers Z21799 to Z21814.
RESULTS
Incidence of penicillin-resistant pneumococci from Nairobi.
Isolates were from a collection of 223 clinically relevant
pneumococci obtained from patients studied at the Well-
come Trust-Kenya Medical Research Institute HIV Project,
Nairobi, during 1991 to 1992. Overall antimicrobial resis-
tance rates were as follows: penicillin, 26%; tetracycline,
35%; erythromycin, 0%; and chloramphenicol, 0.7%. The
MICs of penicillin ranged from <0.008 to 0.5 ,ug/ml. A total
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FIG. 1. Hinfl fingerprints of the PBP 2X gene. The 32P-labeled
Hinfl fragments obtained from the PBP 2X genes of resistant
isolates were fractionated on a polyacrylamide gel and were de-
tected by autoradiography. The PBP 1A genes were from isolates
85983 (lane A), 85990 (lane B), 85997 (lane C), 86003 (lane D), 86007
(lane E), 86012 (lane F), 86014 (lane G), 86016 (lane H), 86022 (lane
I), 100494 (lane J), 100496 (lane K), 100503 (lane L), 100506 (lane M),
100509 (lane N), 100511 (lane 0), 100512 (lane P), 100520 (lane Q),
132206 (lane R), 132207 (lane S), 132223 (lane T), 142145 (lane U),
142162 (lane V), 142163 (lane W), and R6 (lane X). pBR322 DNA
digested with HpaII was used as molecular size markers (left and
right lanes). The sizes of the visible pBR322 HpaII fragments are
622, 527, 404, 309, 242, 238, 217, 201, 190, 180, 160, 147, 123, 110,
90, 76, 67, 34, and 26 bp.
of 23 of the penicillin-resistant pneumococci (MICs of 0.1 to
0.5 ,ug/ml) were chosen for further analysis (Table 1).
Analysis of PBP genes of penicillin-resistant pneumococci.
The PBP 1A, 2B, and 2X genes of each of the 23 resistant
strains were amplified by PCR and were digested with
restriction enzymes that cut frequently, and the sizes of the
resulting fragments were analyzed on a polyacrylamide gel
(gene fingerprints). The restriction enzymes used were those
that were expected to give the largest number of DNA
fragments on the basis of the sequences of the PBP genes
from the penicillin-susceptible strain R6 (6, 14, 18). The
resolution of the fingerprinting method was increased by
analyzing the fragments produced from each gene using at
least two restriction enzymes (see Materials and Methods).
Figure 1 shows the PBP 2X gene fingerprints of the resistant
pneumococci obtained with Hinfl.
PBP genes that gave identical fragments with each of the
restriction enzymes were considered very similar, and prob-
ably identical, in sequence. In a few cases, PBP genes that
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PheSerAspG lySerG luLysG luPheSerAsnValG lyThrArgA laMetLysG luThrThrA LaTyrMetMEetThrAspMetMetLysThrVa lLeuSerTyrG lyThrG lyArgAsn
2464 TTTAGTGATGGGAGTGAAAAAGAGTTCTCTaTGTCGGMCTCGTGCCATGAMGAAACGACAGCCTATATGATGACCGACATGATGAAAACAGTCTTGAGTTATGGMCTGGACGAAATa
GLu Ala Ile Gly
///--T---G-T-----TT- -- -A.-----T--T----GC----C----TC-- TGG- b-d
AtaTyrLeuALaTrpLeuProGlnAlaGlyLvsThrGlvThrSerAsnTyrThrAspGLuGluI leGLuAsnHisILteLysThrSerGlnPheValALaProAspGluLeuPheAlaGLy
2584 GCCTATCTTGCTTGGCTCCCTCAGGCTGGTAAAACAGGAACCTCTAACTATACAGACGAGGAAATTGAAAACCACATCAAGACCTCTCAATTTGTAGCACCTGATGAACTATTTGCTGGC a
Pro Asp LysTyr AsnThrGlyTyr Met Val
--T--C--AC-A----T--A--A--A----G-----T--T-------T---C--------GT-T.-------A-A--GGC-AC----T-AA------TAA-G----TA--T b-d
Tyr AsnThrGlyTyr Ala Met Val///T-----A-ATA--GGT-A------T--A-CC---A-G----T---T e-h
TyrThrArgLysTyrSerMetA laVa lTrpThrG lyTyrSerAsnArgLeuThrProLeuValG lyAsnG lyLeuThrValA laAlaLysVa lTyrArgSerMetMetThrTyrLeuSer
2704 TATACGCGTMATATTCAATGGCTGTATGGACAGGCTATTCTMCCGTCTGACACCACTTGTAGGCMTGGCCTTACGGTCGCTGCCAMGTTTACCGCTCTATGATGACCTACCTGTCT a
Thr IleMet Asp
-----T---G-----T------------T-CA-A-----C-----A--A-G--GG----T--C-A--T.T-------------- ------ -- -- T--- b-d
Ile Asp PheTyr
-----T--C---.--------- G --T-C--A---C- -T-TA-C--T-TG-- T-CTAT--T-A--T--G--------T--A--------T--T------ eh
GluG lySerAsnProG luAspTrpAsnI LeProGLuG lyLeuTyrArgAsnGlyGluPheVa lPheLysAsnGlyAlaArgSerThrTrpSerSerProAlaProGLknG lnProProSer
2824 GMGGMGCAATCCAGAGGATTGGMTATACCAGAGGGGCTCTACAGMATGGAGMTTCGTATTTMAAATGGTGCTCGTTCTACGTGGAGCTCACCTGCTCCACAACAACCCCCATCA a
Asn
------- - -----------------------------.------ .-------------------A-----------------------b-bd
AspLys Gly ThrMet Ser Lys Ala ThrAla Arg Ala Thr
-G-AT-A--C-T-GC--C---C---G- A-T- TC--G--T--G-C--- A-------G-A---CTG-T--CG-----G-----GG----A-- e-h
ThrG luSerSerSerSerSerSerAspSerSerThrSerG lnSerSerSerThrThrProSerThrAsnAsnSerThrThrThrAsnProAsnAsnAsnThrG lnG lnSerAsnThrThr
2944 ACTGaAGTTCMGCTCATCATCAGATAGTTCMCTTCACAGTCTAGCTCAACCACTCCMGCACAAATAATAGTACGACTACCAATCCTAACMTAATACGCMCMTCAAATACAACCa
.-----------.
--- ..
---- -- ------------------------------------
b d
Pro Thr Glu AlaAsnAsn Thr Asn Pro
C-A-----G- GA----A---------------A-----T-------- G-------G-A-AC-AT--A-C. ----AC--G---C----------G e-h
ProAspGlnGlnAsnGLnAsnProGlnProALaGlnPro***
3064 CCTGATCAACAAAATCAGAATCCTCAACCAGCACAACCATAA a
b-d
GLy
----G---- --- C--/// e-h
FIG. 2. Sequences of part of the PBP 1A gene of penicillin-resistant pneumococci. The sequence shown in line a is that of the
penicillin-susceptible strain R6. The nucleotide and amino acid sequences are numbered at the end of each line as by Martin et al. (17). The
other lines show the positions where the nucleotide and amino acid sequences differ from those of strain R6. The sequences are those from
strains 85983 (b), 86007 (c), 86016 (d), 86014 (e), 100511 (f), 132206 (g), and 142145 (h). The position of the Lys-Thr-Gly conserved sequence
motif is underlined. ///, the limits of the sequence that was determined.
appeared to be identical by fingerprinting were found in
isolates of different serotypes. In all of these situations (see
asterisks in Table 1), regions of the PBP gene from an isolate
of each serotype were sequenced (see Materials and Meth-
ods) to establish whether the genes were identical or just
sufficiently similar to give the same fingerprints. The se-
quences of the regions of the PBP genes that were deter-
mined are shown in Fig. 2 to 4.
In all but two cases, PBP genes with identical fingerprints
were confirmed as being identical by DNA sequencing. The
exceptions were the PBP 2B genes of isolates 132206,
142145, 100511, and 100503 and 85990, 86022, and 86012 and
the PBP 2B genes of isolates 86003 and 100494 and 100496.
In these two cases, the PBP 2B genes could not be distin-
guished by fingerprinting, but DNA sequencing showed that
they differed slightly in sequence (compare lines d and e with
f and line g with h in Fig. 3). The PBP 2B genes were
therefore given different allele numbers in Table 1.
Among the 23 penicillin-resistant pneumococci, 8 different
alleles of the PBP 1A gene, 10 different alleles of the PBP 2B
gene, and 9 different alleles of the PBP 2X gene were
distinguished. The digitized fingerprint patterns of each of
the different alleles of the three PBP genes are shown in Fig.
5 to 7.
Classification of penicillin-resistant pneumococci into fin-
gerprint groups and ribotype groups. Isolates were grouped
into those that appeared to have identical forms of each of
the three PBP genes (fingerprint groups). The 23 resistant
isolates fell into 11 fingerprint groups (Table 1). Classifica-
tion into fingerprint groups was carried out blind, in the
absence of any knowledge of serotypes. As expected, three
pairs of isolates obtained from patients during a single
infection (100506 and 132207 from patient 2, 142162 and
142163 from patient 12, and 100512 and 100520 from patient
15) were indistinguishable. One further isolate (85983) from
patient 2 was clearly distinguishable from the two other
isolates from this patient. This was not surprising, since
isolate 85983 was from an episode of pneumococcal disease
that occurred over 7 months before the other strains were
isolated. Isolates 86014 and 100509 from patient 1 were
indistinguishable, even though they were isolated from sep-
arate episodes of pneumococcal disease occurring over 4
months apart.
The grouping of the resistant strains obtained by ribotyp-
ing correlated well with the grouping achieved by PBP gene
fingerprinting. The 11 different ribotype patterns found
among the 23 resistant isolates are shown in Fig. 8. With the
exception of fingerprint group IV, isolates in the same
fingerprint group had the same ribotype. The two isolates of
fingerprint group IV (85997 and 132223) differed in ribotype
but were shown to be extremely closely related, since they
expressed identical isoenzymes for each of 18 enzymes
analyzed by MLEE (Table 2). Isolates in different PBP
fingerprint groups gave distinct ribotypes, with the exception
of the isolates in fingerprint groups I and II, which could not
be distinguished by ribotyping. The isolates of fingerprint
groups I and II contained identical forms of PBP 1A but
different forms of both PBP 2B and 2X and were extremely
closely related since they were indistinguishable by MLEE
(18 enzymes examined) as well as by ribotyping.
Except in one case, isolates classified as being members of
the same fingerprint group were of the same serotype and
required very similar MICs of penicillin. Fingerprint group
II, however, consisted of two isolates of serotype 7 and two
isolates of serotype 14. These four isolates were kindly
reserotyped by both Colindale and the Statens Seruminstitut
and were confirmed to be serotypes 7 (7B) and 14. Two
regions of the PBP 1A, 2X, and 2B genes were sequenced
from at least one serotype 7B and one serotype 14 isolate
(see asterisks in Table 1). No differences between the PBP
gene sequences of the isolates of serotype 7B and 14 were
found. The isolates of fingerprint group II were indistinguish-
able by either MLEE or ribotyping (see above), possessed
identical PBP 1A, 2B, and 2X genes, and were therefore
identical by all criteria except serotype.
In most cases, particular alleles of each PBP gene were
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ThrLeuGlnGLyLysArgSerValLysGluIL eHisLeuAspLysTyrGlyAsnMetGluSerValAspThrI leGluGluGlySerLysGlyAsnAsnI leLysLeuThrI leAspLeu
1052 ACCTTACaGGMAACGCTCGGTAAMGMATCCATCTGGATAMTATGGCMTATGGMAGCGTGGATACAATTGAGGMGGTAGTMGGGAMCAATATCMACTGACCATTGATTTGa
//---------------------------------------------------------------------------------- b, c
AlaPheG lnAspSerVa lAspA laLeuLeuLysSerTyrPheAsnSerG luLeuG luAsnG lyGlyA laLysTyrSerG luG lyVa lTyrA laValA laLeuAsnProLysThrG lyA la
1172 GCTTTCCAAGATAGCGTGGATGCTTTACTGAAAAGTTATTTCAATTCTGAGCTAGaMTGGTGGAGCCAAGTATTCTGAAGGTGTCTATGCAGTCGCCCTTMCCCAAAAACAGGTGCGa
--C-------------------------------------- ---------------------------------------------------------------------- b, c
ValLeuSerMetSerGlyI leLysHi sAspLeuLysThrGlyGluLeuThrProAspSerLeuGlyThrValThrAsnValPheValProGlySerVa LVatLYsAaALaThrI leSer
1292 GTTTTGTCTATGTCAGGGATTAMCATGACTTGAAAACGGGAGAGTTGACGCCTGATTCCTTGGGAACGGTAACCAATGTCTTTGTTCCAGGTTCGGTTGTCAAGGCGGCGACCATCAGC a
//-------------------------------------------------------------- d,e
/f---------------C.-- _C_
Ala
///- -- -------------------_
SerGLyTrpGluAsnGlyValLeuSerGlyAsnGLnThrLeuThrAspGtlnSerI LeValPheGLnGLySerALaProI leAsnSerTrpTyrThrGlnAlaTyrGlySerPheProI le
1412 TCAGGTTGGGAAAATGGAGTCTTGTCAGGAAACCAGACCTTGACAGACCAGTCCATTGTCTTCCMGGTTCAGCTCCCATCMTTCTTGGTATACTCAGGCTTACGGTTCATTCCCTATC
Pro
A_>_
ThrALaVaLGlnAlaLeuGluTyrSerSerAsnThrTyrMetVaLGlnThrAlaLeuGlyLeuMetGlyGflnThrTyrGlnProAsnMetPheVaI
1532 ACAGCGGTCCAAGCTCTGGAGTATTCATCAAATACCTATATGGTCCAAACAGCCTTAGGTCTTATGGGGCAAACCTATCAACCCAATATGTTTGT(
GLu Ala Ile
Ala
. g
- h
: a
Asp
---A--C----A---------G--T b, c
AlaPheSerArgProMet
-GCCTT--CTA-GC--A-G--G--T d,e
AlaPheSerValProMet
-GCCTT--CT-TGC--A-G--G--T f
g----
--g
- C---------------- h
lGlyThrSerAsnLeuGluSerAla
CGGCACCAGCAATCTAGAGTCTGCT a
Leu Asn
TTTA--T-A----T----A--C--C b, c
d,e
Ala
--G--A--T--------------------C---G-T-----------------TC----------------G-----C-----T-----------------------C------------ f
GLu Ala Ile
------GG----CT--------T--G---G----C-----------G--T--G--CA----------G-----C------------------------------------------ g
Glu Ala Ile
-------GG--CT----------T--G---G----C-----------G--T--G--CA----------G C --------------------------------- h
MetGluLysLeuArgSerThrPheGlyGluTyr
1652 ATGGAGAAACTGCGTTCAACCTTTGGCGAATAT a
Gly
----G------T-----G--A---/// b, c
Gly
----GT---T/-------------- d,e
Gly
----GT---T--------------/ f
Gly PheGly
--G----TTCG----------// 9
Gly PheGly
---G----TTCG----------/// h
AsnAlaPheGlyGlnPheAspAsnTyrThrProMetGlnLeuAlaGlnTyrValAlaThrI leAlaAsnAsnGlyValArgValAlaProArgI leValGluGlyI leTyrGlyAsnAsn
1772 AATGCCTTTGGGCAGTTTGATAACTATACGCCGATGCAGTTGGCTCAGTATGTAGCAACTATTGCAAATAATGGTGTTCGTGTGGCTCCTCGTATTGTTGAAGGCATTTATGGTAATAAT a
///A-------------------------A------ b,c
Asp
//--------------G---------------.G-------------------------------------------------- d,e
/I. f
Asp
/---------------------------------------------------------------G-------------------------------------------------- g
Asp
-//--- -.-----------------------G-------------------------------------------------- h
AspLysGlyGlyLeuGlyAspLeuI leGlnGlnLeuGlnProThrGluMetAsnLysValAsnI LeSerAspSerAspMetSerI leLeuHisGlnGlyPheTyrGlnValAlaHisGly
1892 GATAAGGGAGGACTGGGTGACTTGATTCAGCAACTGCAACCGACAGAGATGAATAAGGTCAATATATCCGACTCCGATATGAGCATCTTGCACCAAGGTTTTTATCAGGTTGCCCATGGT a
Val
-----------C--A--C-----------------------------------------------------------------TG----------------------------T-----G b,c
Val
Val
-T-----G d,e
-T-----G f
g
Val
.------------c-CT-------------------------------------------------------T--------TG----------------------------T-----G h
ThrSerGlyLeuThrThrGLyArgAlaPheSerAsnGlyALaLeuValSerI LeSerGLyLysThrGtLThrALaGluSerTyrValAlaAspGlyGlnGlnALaThrAsnThrAsnAla
2012 ACTAGTGGATTGACAACTGGACGTGCCTTTTCAAATGGTGCCTTGGTATCCATTAGCGGaMACAGGTACAGCCGMAGCTATGTGGCAGATGGTCAGCMGCMCCAATACCAATGCGa
Glu
CT--,----------------------------------------------------------G-----T---------------------------G--------------------b,c
C--6---------------------------------------------------------G------------------------------------------------------ d,e
-
C.----- ------------------------------------------------G------------------------------------------------------ f
Ala GLuGLy Glu Asn
--------------------------AA-------------AGCT.-----------TT--T---------T--------T-----T-AG-GA-----AG----T-A------------T g
Ala GluGly Glu Asn
-----------------------A--------------A GCT--------T--T---------T--------T-----T AG-GA-----AG----T-A------------T h
ValAlaTyrAlaProSerAspAsnProGlnI LeAlaValAlaVaLValPheProHi sAsnThrAsnLeuThrAsnGlyValGlyProSerI leAlaArgAspI leI leAsnLeuTyrGln
2132 GTGGCCTATGCCCCATCTGATAATCCCCAMTCGCTGTCGCAGTGGTCTTTCCTCATAATACCMTCTAACAAATGGTGTAGGACCTTCCATTGCGCGTGACATTATCAATCTCTATCAA a
--------------------------------------T--------------------------------------------G-----------------------------G------ b, c
--------------------------------------T--------------------------------------------.G-----------------------------G------ d,e
--------------------------------------T-----------------------------------G---------------------------------G------ f
Asn
-----------A-----A--------T-----------A--T--T--------G-----C--------G-----------C--G-----T-----------T--------C------A-C g
---------A-----A--------T-----------A--T--T--------G-----------------------------------------------------------G------ h
LysTyrHisProMetAsn***
2252 AAATACCATCCAATGAACTAGAAAGGAAATTA a
Leu
----------T------------/ b,c
-----------G-----------/ d,e
-----------G-----------/ f
GlnHis
CC--Cf/ g
.f/I_______-_--------/ h
FIG. 3. Sequences of parts of the PBP 2B gene of penicillin-resistant pneumococci. The sequences of two regions of the gene of strain R6
are shown in line a. The sequences are numbered as by Dowson et al. (7). The other sequences are from strains 85983 (b), 142163 (c), 100511
(d), 132206 (e), 85990 (f), 86003 (g), and 100494 (h). The positions of the Ser-X-X-Lys, Ser-X-Asn, and Lys-Thr-Gly conserved sequence
motifs are underlined.
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ULLuGLyIeThnrGLuAspPheVaLtrpArgAspILeLeuTyrLflnSerAsnTyrGLuProGLySerT rMetLvsvaLMetMetLeuALaALaALaI LeAspAsnAsnThrPheProGly
946 GAAGGCATTACAGAGGACTTTGaGGCGTGATATCCTTTACCAAAGTAACTATGAGCCAGGTTCCACTATGAAAGTGATGATGTTGGCTGCTGCTATTGATAATATACCTTTCCAGGAa
Ser
///-- - -------------C-- --A-T bd/// -------- eg
GLyGluValPheAsnSerSerGluLeuLysI leAlaAspAlaThrI LeArgAspTrpAspValAsnGluGlyLeuThrGlyGlyArgMetMetThrPheSerGlnGlyPheALaHi sSer
1066 GGAGAAGTCTTTAATAGTAGTGAGTTAAAAATTGCAGATGCCACGATTCGAGATTGGGACGTTMTGAAGGATTGACTGGTGGCAGAATGATGACTTTTTCTCAAGGTTTTGCACACTCA a
Tyr Asp Thr GLy Leu
---TA--C---C --A------A--G ---G------- . T------T--T GAC--TG-G-----------C-TA-------C--T.-----Cbd
Va l GLy Leu
. -----C----C---A---A-G---TG -
-------.TG-T------A--C------G-C--T-T----
SerAsnVa lG LyletThrLeuLeuG luG lnLysMetG lyAspAlaThrTrpLeuAspTyrLeuAsnArgPheLysPheG lyVa lProThrArgPheG lyLeuThrAspG luTyrA laG ly
1186 AGTAACGTTGGGATGACCCTCCTTGAGCAAAAGATGGGAGATGCTACCTGGCTTGATTATCTTAATCGTTTTAAATTTGGTGTTCCGACCCGTTTCGGTTTGACGGATGAGTATGCTGGT
Ser
*e-g
*a
- T----A--GT-A---A----A- ----- T--T-G-----A--C--C-----------G-C--A-T--C--T-C---/// b-d
ALa
--- -G-T- -T-G---T-A--C--C-- ----A--------.C- e-g
GLnLeuProALaAspAsnILeVaLAsnI LeALaGLnSerSerPheGLyGLnGLyILeSerVaLThrGLnThrGLnMetILeArgALaPheThrALaI LeALaAsnAspGlyVaLMetLeu
1306 CAGCTTCCTGCGGATATATTGTCAACATTGCGCAAAGCTCATTTGGACAGGGATTTCAGTGACCCAGACGCAAATGATTCGTGCCTTTACAGCTATTGCTAATGACGGTGTCATGCTG a
GluProLysPhelteSerAlaI leTyrAspProAsnAspGlnThrAlaArgLys
1426 GAGCCTAAATTTATTAGTGCCA M ATGATCCAAATGATCAAACTGCTCGGAAA
Ile
_ *_Tt_- e-g
-f_____/f/ / e-g
ValGlyLeuThrAspTyrIlePheSerAlaValSerMetSerProAlaGluAsnProAspPheIleLeuTyrValThrValGLnGlnProGluHisTyr
1687 GTCGGGTTAACCGACTATATTTTCTCGGCTGTATCGATGAGTCCGGCTGAAAATCCTGATTTTATCTTGTATGTGACGGTCCAACAACCTGAACATTAT a
AsnAsn Val ALa Asn
///TA-A-C - T G C- AC--T---- --C----------A.T----G-----. b-d
SerGlyI leGlnLeuGlyGluPheAlaAsnProI LeLeuGluArgAlaSerAlaMetLysAspSerLeuAsnLeuGlnThrThrAlaLysAlaLeuGluGlnVaLSerGlnGLnSerPro
1786 TCAGGTATTCAGTTGGGAGAATTTGCCAATCCTATCTTGGAGCGGGCTTCAGCTATGAAAGACTCTCTCAATCTTCAAACAACAGCTAAGGCTTTGGAGCMGTMGTCAACMAGTCCT a
Thr
_A-A- b-d
TyrProMetProSerValLysAspI LeSerProGlyAspLeuAlaGluGluLeuArgArgAsnLeuValGlnProI LeValValGLyThrGLyThrLysI LeLysAanSerSerAlaGlu
1906 TATCCTATGCCCAGTGTCaGGATAMCACCTGGTGAMAGCAGAGAATTGCGTCGCATCTTGTACAACCCATCGTTGTGGGACAGGACGAGATTAAAACAGTTCTGCTGMa
---------T-.-------.--- ------------ b-d
Ala Ile ALa Ile Glu Val
///G-C---T-CA--C-----C---G--G-CC--A----A -G- -A--- A----- .A--A G-ATCA---TA--- e-g
GLuGlyLysAsnLeuALaProAsnGLnGLnVaLLeuI LeLeuSerAspLysALaGluGluValProAspMetTyrGlyTrpThrLysGluThrAlaGluThrLeuAlaLysTrpLeuAsn
2026 GaGGGAAGAATCTTGCCCCGAACCAGCAAGTCCTTATCTTATCTGATAAAGCAGAGGAGGTTCCAGATATGTATGGTTGGACAMGGAGACTGCTGAGACCCTTGCTAAGTGGCTCAATa
Ala Phe
Thr Lou ALa ALaPheSer
----A-CC----T--T------T-CC- ------ --A---------- -------A-CA--C-A--AG-TT--T------T-A--- e-g
I LeGLuLeuGLuPheGLnGLySerGLySerThrVaLGLnLysGLnAspVaLArgALaAsnThrALaI LeLysAspIleLysLysI LeThrLeuThrLeuGLyAsp*'*
2146 ATAGAACTTGAATTTCMGGCTCGGGCTCTACTGTGCAGAAGCMGATGTTCGTGCTAACACAGCTATCAAGGACATTAAAMMTTACATTAACTTTAGGAGACTAATATGTTTATTTC a
GLu
ILeVaL GLu
----A T----G--T--A---- ---T-- - ---// e-g
FIG. 4. Sequences of parts of the PBP 2X gene of penicillin-resistant pneumococci. The sequence of two regions of the gene of strain R6
are shown in line a. The sequences are numbered as by Laible et al. (14). The other sequences are those from strains 100511 (b), 132206 (c),
142145 (d), 85983 (e), 86007 (f), and 86016 (g). The positions of the Ser-X-X-Lys and the Ser-X-Asn conserved sequence motifs are underlined.
restricted to a single fingerprint group. However, there were
three cases in which PBP genes with identical fingerprints
were found in isolates from different fingerprint groups.
Allele 1 of the PBP 1A gene was found in fingerprint groups
I and II, allele 5 of the PBP 2B gene was found in isolates of
fingerprint groups V and X, and allele 7 of the PBP 1A gene
and allele 8 of the PBP 2X gene were found in isolates of
fingerprint groups VIII, IX, and X. In all cases, the identities
of the PBP genes in different fingerprint groups were con-
firmed by partial DNA sequencing.
MLEE. The overall relatedness of one isolate from each
ribotype group was assessed by MLEE. Of the 18 enzymes
that were assayed in these isolates, the following 10 enzymes
were monomorphic: 6-phosphogluconate dehydrogenase,
hexokinase, leucyl-glycyl-glycine peptidase, fructokinase,
glyceraldehyde-3-phosphate dehydrogenase, leucine amin-
opeptidase, esterase, lactate dehydrogenase, indophenol ox-
idase, and alcohol dehydrogenase. The differences among
strains in the mobilities of the 18 enzymes (Table 2) were
converted to a distance matrix, and a neighbor-joining tree
was constructed (Fig. 9).
DISCUSSION
Penicillin-resistant pneumococci isolated in the outpatient
clinic in Nairobi were most commonly of serotype 14 or 19.
However, resistance was also found in isolates of serotypes
7, 9, 10, 11, 15, 16, 19, and 23. At present, approximately
26% of the pneumococci from this Nairobi clinic have
m A _C D
0 -_-- 0
No- -_____o
--4_
mA BC D AB
FIG. 5. Fingerprints of the PBP lA genes of penicillin-resistant
pneumococci. The digitized patterns of the Hinfl (left part of figure)
and DdeI plus MseI (right part) fragments obtained from each of the
different allelic forms of the PBP lA gene are shown. m, pBR322 x
HpaII size markers. The fingerprints are from strains 100509 (A),
85990 (B), 85997 (C), 142163 (D), 100494 (E), 100512 (F), 86016 (G),
86003 (H), and R6 (I).
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FIG. 6. Fingerprints of the PBP 2B genes of penicillin-resistant
pneumococci. The digitized patterns of the Hinfl (left part) and StyI
(right part) fragments obtained from each of the allelic forms of the
PBP 2B genes are shown. The 2 and 3 alleles and the 6 and 10 alleles
cannot be distinguished by fingerprinting with these enzymes but
were shown to differ by sequencing (see text). m, size markers. The
fingerprints are from strains 100509 (A), 132206 (B), 85990 (C), 85997
(D), 142163 (E), 100494 (F), 100512 (G), 86016 (H), 86007 (I), 86003
(J), and R6 (K).
2.0
FIG. 8. Ribotyping patterns of penicillin-resistant pneumococci.
The lanes correspond to the ribotyping patterns 1 to 11 shown in
Table 1. A digoxigenin-labeled HindIII digest of bacteriophage
lambda was used to provide molecular size markers (M). Sizes are
shown in kilobase pairs.
intermediate-level resistance to penicillin (MICs, 0.1 to 1
,ug/ml). The maximum MIC of benzylpenicillin for the pneu-
mococcal isolates was 0.5 p,g/ml, and no isolates with
high-level resistance to penicillin were identified.
All of the penicillin-resistant pneumococci had PBP 1A,
2B, and 2X gene fingerprints that differed from those of the
penicillin-susceptible strain R6. This is consistent with the
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FIG. 7. Fingerprints of the PBP 2X genes of penicillin-resistant
pneumococci. The digitized patterns of the Hinfl (left part) and DdeI
plus MseI (right part) fragments obtained from each of the allelic
forms of the PBP 2X gene are shown. m, size markers. The
fingerprints are from strains 100509 (A), 132206 (B), 85990 (C), 85997
(D), 142163 (E), 100494 (F), 100512 (G), 86016 (H), 86003 (I), and R6
(J).
finding that pneumococci with benzylpenicillin MICs of 20.1
,ug/ml produce altered forms of PBPs 1A, 2B, and 2X that
have sequences very different from those of penicillin-
susceptible pneumococci. In most cases, PBP gene finger-
printing with multiple restriction enzymes provides a reliable
method for identifying PBP genes that are identical in
sequence. The utility of this method depends on the fact that
the PBP genes of resistant pneumococci are very highly
variable in sequence. Different fingerprints clearly imply
distinct PBP genes (differences in DNA modification will not
occur, since all of the DNA is unmodified because of the use
TABLE 2. Allele profiles of penicillin-resistant pneumococcia
Allele
Isolate
GD2 NSP ADK CAK PLP PGI LGP DIA
86014 2 1 2 2 3 2 3 3
100503 2 1 2 2 3 2 3 3
86022 1 1 3 3 3 2 3 3
85997 1 1 2 2 3 2 3 3
132223 1 1 2 2 3 2 3 3
142163 1 2 2 2 3 2 3 1
100494 3 2 2 2 2 2 3 3
86016 1 1 2 2 2 2 2 3
86007 2 1 2 2 3 2 3 1
85983 1 1 2 2 2 2 2 3
100520 1 2 1 1 1 1 1 1
86003 1 3 2 2 2 2 2 2
a GD2, glyceraldehyde-3-phosphate dehydrogenase (NADP dependent);
NSP, nucleoside phosphorylase; ADK, adenylate kinase; CAK, carbamylate
kinase; PLP, phenylalanyl-leucine peptidase; PGI, phosphoglucose isomer-
ase; LGP, leucyl-glycyl-glycine peptidase; DIA, diaphorase. The other 10
enzymes that were assayed in these isolates (see Materials and Methods) were
monomorphic.
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FIG. 9. Overall relatedness of penicillin-resistant pneumococci.
A neighbor-joining tree (26) was constructed from the differences
among isolates in the electrophoretic mobilities on starch gels of 18
enzymes. The bar at the bottom of the figure corresponds to a
genetic distance of 0.05, corresponding to a difference at 1 of the 18
loci. The most distantly related isolates (e.g., 86014 and 100520) are
separated by a genetic distance of 0.44 and differ at all of the 8
polymorphic loci.
of PCR), but genes with very similar but not identical
sequences may produce identical fingerprints. After exten-
sive use of this procedure, together with DNA sequencing,
to analyze the PBP genes of penicillin-resistant pneumococci
isolated worldwide, we have uncovered a few examples of
PBP genes that are indistinguishable by fingerprinting but
that are different in sequence (5). In the present study, the
PBP 2B genes of fingerprint groups II and III and of groups
VI and XI were shown to be different in sequence although
they were not distinguished by fingerprinting. Direct se-
quencing of highly variable regions of each of the PBP genes
provides a convenient method that can be used to check the
identity of PBP genes when required.
Although isolated from a small region over a limited time
period, the 23 penicillin-resistant pneumococci were very
diverse and could be divided into 11 different PBP fingerprint
groups and 11 different ribotype groups. There was a good
correlation between the groupings of the isolates obtained by
PBP fingerprinting and ribotyping, with the exception of the
two isolates in fingerprint group IV which had distinct
ribotypes. However, MLEE suggested that the latter iso-
lates were members of the same clone which presumably
differ slightly around the rRNA genes. It is, therefore, likely
that the fingerprint groups in Table 1 define distinct penicil-
lin-resistant clones. It should be stressed that this will not
always be the case, since we have described examples of
penicillin-resistant pneumococci from Spain that have iden-
tical alleles of each of the three PBP genes (i.e., the same
fingerprint group) but which can be divided into two groups,
of different serotypes, that are not closely related when
analyzed by MLEE (4). In this case, horizontal gene transfer
is believed to have distributed the same resistance genes into
two genetically diverse pneumococcal lineages to produce
new penicillin-resistant clones (4).
Isolates in each fingerprint group were of the same sero-
type and required similar MICs of benzylpenicillin, except
for fingerprint group II, in which two isolates were serotype
7B and two isolates were serotype 14. DNA sequencing
confirmed that these four isolates possessed identical altered
forms of PBPs 1A, 2B, and 2X. The occurrence of indistin-
guishable isozymes at each of the 18 enzyme-encoding loci
that were examined indicates that the serotype 7B and 14
isolates are members of the same clone. This view is
supported by ribotyping, which also failed to distinguish
among these four isolates. A similar example of penicillin-
resistant pneumococci that are identical by all criteria,
except serotype, has been described previously. In that
case, a multiply antibiotic-resistant isolate of serotype 19F
from Spain was identical by all criteria (except serotype) to
the members of the multiply antibiotic-resistant serotype
23F clone that is common in Spain (4). Subsequently,
multiply antibiotic-resistant serotype 19F isolates that are
members of the serotype 23F clone were identified in a
second Spanish hospital (29) and in California (20). In the
absence of information about the genetic basis of capsular
biosynthesis in pneumococci, it is not possible to investigate
further the reason why isolates that are apparently indistin-
guishable have different serotypes. However, it appears that
some type of serotype change has occurred in both of these
examples, perhaps mediated by the horizontal transfer and
recombinational replacement of genes specifying capsular
type (4).
The isolates of fingerprint group II could not be distin-
guished from those of fingerprint group I by either ribotyping
or MLEE. The isolates of these two fingerprint groups are
therefore members of the same clone. In addition, all of
these isolates possess PBP 1A genes that are identical by
both fingerprinting and DNA sequencing (although they have
clearly different PBP 2X and 2B genes) and are mostly
serotype 14. It seems likely that the isolates of fingerprint
groups I and II are derived from a recent common ancestor,
possibly of serotype 14, which acquired an altered PBP 1A
gene to result in a slightly increased MIC for penicillin.
Subsequently, the latter isolate may have gained higher-level
penicillin resistance on two separate occasions by the acqui-
sition of different altered PBP 2X and PBP 2B genes to
produce isolates that we separate into fingerprints I and II.
As discussed above, a change of serotype appears addition-
ally to have occurred within fingerprint group II.
We found three examples among the Kenyan isolates in
which the same altered PBP gene was found in isolates of
different fingerprint groups. In all three cases, the identities
of the PBP genes in each fingerprint group were established
by DNA sequencing. The presence of allele 1 of the PBP 1A
gene in isolates from fingerprint groups I and II may not
represent an example of horizontal spread of the PBP 1A
gene, since these isolates are members of a single clone (see
above). The other two cases probably do involve horizontal
transfer of PBP genes. Thus, the isolates of fingerprint
groups V and X possessed the same PBP 2B allele but
differed both by ribotype and by serotype and were shown
by MLEE to be members of distantly related pneumococcal
lineages (Fig. 9). Isolates of fingerprint groups VIII, IX, and
X, which possessed the same PBP 1A allele, also differed by
both ribotype and serotype, although the former and latter
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strains could not be distinguished by MLEE. However,
horizontal transfer of the PBP 1A gene is likely to have
occurred, since isolates of fingerprint groups VIII and X
were not closely related to the isolate of fingerprint group IX
(Fig. 9).
Serotyping, or phage typing, is often used to distinguish
bacterial isolates for epidemiological studies. However, it is
well established that these methods are inadequate, since
they are based on differences in cell surface structures that
evolve rapidly and which may be subject to convergent
evolution (28). In contrast, ribotyping and, particularly,
MLEE provide much more satisfactory methods for estimat-
ing the relatedness of different isolates of the same species,
since directly or indirectly they examine genetic diversity
that is mostly believed to be selectively neutral. The heter-
ogeneity among both the serotype 14 and the serotype 19
penicillin-resistant pneumococci from a single clinic con-
firms the inadequacy of serotyping alone for epidemiological
studies of penicillin-resistant pneumococci.
In conclusion, our results demonstrate the diversity that
can exist within penicillin-resistant pneumococci isolated
within a short time period from a single clinic. They also
illustrate the complex relationships between resistant pneu-
mococcal isolates, probably arising from the horizontal
transfer between lineages of PBP genes and genes specifying
capsular type, which can be revealed only by methods that
can assess both the relatedness of individual PBP genes and
the overall genetic relatedness of isolates.
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